中金基金管理有限公司关于旗下基金投资关联方承销期内承销证券的公告

Core Points - The article discusses the participation of China International Capital Corporation (CICC) in the initial public offering (IPO) of Baiao Saitou (Beijing) Pharmaceutical Technology Co., Ltd. on the Sci-Tech Innovation Board [1] - The IPO price was set at 26.68 yuan per share, determined through a comprehensive evaluation of the company's investment value and market conditions [1] Group 1 - CICC acted as the lead underwriter for the IPO of Baiao Saitou [1] - The pricing of the IPO considered factors such as comparable company valuations and market demand [1] - The offline issuance did not incur transfer fees or stamp duties for the allocation recipients [1]